NPI: 1295788735 · SUGAR LAND, TX 77479 · Ambulatory Surgical Clinic/Center · NPI assigned 05/18/2006
Authorized official LARAWAY, DENNIS controls 20+ related entities in our dataset. Read more
| Authorized Official | LARAWAY, DENNIS (CFO) |
| NPI Enumeration Date | 05/18/2006 |
Other providers sharing the same authorized official: LARAWAY, DENNIS
| Year | Claims | Total Paid |
|---|---|---|
| 2019 | 15 | $119.49 |
| 2020 | 692 | $228K |
| 2021 | 20,721 | $2.20M |
| 2022 | 29,946 | $2.67M |
| 2023 | 27,236 | $2.80M |
| 2024 | 14,934 | $1.23M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 12,354 | 11,683 | $5.41M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 13,631 | 13,275 | $1.64M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1,812 | 1,654 | $493K |
| 80053 | Comprehensive metabolic panel | 8,066 | 7,174 | $350K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 11,149 | 9,655 | $211K |
| 81001 | 7,577 | 7,074 | $149K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 640 | 561 | $120K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2,710 | 2,619 | $108K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1,957 | 1,810 | $107K |
| 87400 | 2,505 | 1,267 | $79K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 196 | 173 | $41K |
| 71045 | Radiologic examination, chest; single view | 1,824 | 1,689 | $35K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 239 | 230 | $31K |
| 76819 | Fetal biophysical profile; without non-stress testing | 153 | 75 | $30K |
| 70450 | Computed tomography, head or brain; without contrast material | 911 | 859 | $29K |
| 84484 | 2,534 | 1,778 | $27K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1,512 | 1,183 | $20K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 212 | 204 | $19K |
| 83690 | 1,354 | 1,240 | $18K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 278 | 270 | $16K |
| 84703 | 442 | 412 | $15K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 648 | 201 | $15K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 121 | 118 | $14K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1,185 | 334 | $14K |
| 93975 | 73 | 59 | $14K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 2,525 | 2,257 | $13K |
| 96361 | Intravenous infusion, hydration; each additional hour | 450 | 380 | $11K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1,105 | 996 | $10K |
| 87807 | 229 | 227 | $8K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 277 | 134 | $8K |
| 83880 | 762 | 715 | $7K | |
| 71046 | Radiologic examination, chest; 2 views | 155 | 147 | $7K |
| 84450 | 238 | 208 | $6K | |
| 84075 | 241 | 208 | $5K | |
| 76801 | 56 | 46 | $5K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 817 | 774 | $5K |
| 84702 | 277 | 241 | $5K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 460 | 451 | $4K |
| 96375 | Therapeutic injection; each additional sequential IV push | 703 | 551 | $4K |
| 82247 | 241 | 208 | $3K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 121 | 116 | $3K |
| 84155 | 238 | 208 | $3K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 42 | 12 | $2K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 48 | 47 | $2K |
| 85730 | 1,112 | 1,030 | $2K | |
| 82550 | 905 | 830 | $2K | |
| 85610 | 1,190 | 1,069 | $2K | |
| 87081 | 64 | 60 | $1K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 12 | 12 | $1K |
| 83735 | 808 | 656 | $1K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 282 | 187 | $1K |
| 82040 | 240 | 207 | $1K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 18 | 14 | $951.85 |
| J3490 | Unclassified drugs | 209 | 112 | $942.23 |
| 96376 | 127 | 80 | $925.01 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 52 | 51 | $889.00 |
| 80076 | 27 | 26 | $651.91 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 377 | 336 | $602.76 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 52 | 51 | $600.11 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 545 | 418 | $573.86 |
| 86900 | 201 | 193 | $329.77 | |
| 86901 | 188 | 180 | $308.05 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1,409 | 1,244 | $302.38 |
| 83605 | 130 | 112 | $280.31 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 99 | 97 | $260.07 |
| 97162 | 12 | 12 | $235.98 | |
| 87040 | 57 | 50 | $199.97 | |
| 84145 | 32 | 28 | $180.91 | |
| 86850 | 12 | 12 | $180.42 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 16 | 16 | $128.45 |
| 72125 | Computed tomography, cervical spine; without contrast material | 14 | 14 | $127.60 |
| 83036 | Hemoglobin; glycosylated (A1C) | 53 | 49 | $111.84 |
| 36000 | 14 | 12 | $108.15 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 549 | 529 | $102.45 |
| 84100 | 153 | 124 | $100.52 | |
| 81025 | 14 | 14 | $84.07 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 500 | 479 | $63.74 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 92 | 81 | $62.44 |
| 82947 | 180 | 117 | $53.68 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 71 | 66 | $43.90 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 37 | 35 | $31.56 |
| J2704 | Injection, propofol, 10 mg | 188 | 180 | $30.67 |
| G0378 | Hospital observation service, per hour | 27 | 26 | $21.81 |
| 84443 | Thyroid stimulating hormone (TSH) | 15 | 13 | $14.11 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 350 | 345 | $10.56 |
| 80061 | Lipid panel | 13 | 12 | $5.99 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 30 | 28 | $3.31 |